Page last updated: 2024-09-03

4-carbamoylimidazolium 5-olate and Adenocarcinoma

4-carbamoylimidazolium 5-olate has been researched along with Adenocarcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, K; Miyazaki, T; Ogawa, M; Ohno, R; Ota, K; Sakai, Y; Suzuoki, Y; Uzuka, Y; Yamada, K; Yoshida, T1

Trials

1 trial(s) available for 4-carbamoylimidazolium 5-olate and Adenocarcinoma

ArticleYear
[Phase I study and early phase II of SM-108 (4-carbamoylimidazolium-5-olate) in lung cancer. SM-108 Study Group].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:1

    Topics: Adenocarcinoma; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Evaluation; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Purines

1989